Clinical trial
A Randomised Phase III Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With Carcinoma of an Unknown Primary (CUP)
NCT01540058 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Phase III Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With Carcinoma of an Unknown Primary (CUP)
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 22, 2012
- Completion date
- August 27, 2019
- Enrollment
- 243 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.